Jim Cramer would be a buyer of Walt Disney if the stock were to trend lower. “I want to buy…
Read More »Investment strategy
Medical device maker Abbott Laboratories on Wednesday delivered better-than-expected quarterly results and upped its earnings guidance for the third straight…
Read More »David Solomon, Chairman & CEO Goldman Sachs, speaking on CNBC’s Squawk Box at the World Economic Forum Annual Meeting in…
Read More »About 165 million Americans get their health insurance through work, and yet most don’t spend much time considering what their employer is offering…
Read More »About 165 million Americans rely on employer-sponsored health insurance, and yet workers may still not get the coverage they want —…
Read More »(This is CNBC Pro’s live coverage of Wednesday’s analyst calls and Wall Street chatter. Please refresh every 20-30 minutes to…
Read More »Source: Recursion Pharmaceuticals AI drug pioneer Recursion Pharmaceuticals said Wednesday that one of its experimental treatments hit a key milestone.…
Read More »(This is CNBC Pro’s live coverage of Tuesday’s analyst calls and Wall Street chatter. Please refresh every 20-30 minutes to…
Read More »GE Healthcare ‘s quiet outperformance is becoming harder to tune out — and its new drug used in radiology to…
Read More »Blockchain technology and tokenization could challenge the traditional ETF model. Janus Henderson said recently that it’s partnering with Anemoy Limited…
Read More »